Brokers Set Expectations for ADAP Q1 Earnings
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Adaptimmune Therapeutics in a research note issued on Tuesday, March 25th. Leerink Partnrs analyst J. Chang expects that the biotechnology company will post earnings per share of ($0.10) for the […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Stock analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Adaptimmune Therapeutics in a research note issued on Tuesday, March 25th. Leerink Partnrs analyst J. Chang expects that the biotechnology company will post earnings per share of ($0.10) for the […]
